Metformin Hydrochloride Sustained Release Tablets
Formulation and In-Vitro Evaluation of Metformin Hydrochloride Sustained Release Tablets
... individuals. Metformin hydrochloride is a first line biguanide hypoglycemic agent used in the treatment of non insulin dependent diabetes mellitus, not responding to dietary ...acidosis. Metformin ...
6
Preparation and in Vitro Drug Release Evaluation of Once Daily Metformin Hydrochloride Sustained Release Tablets
... Metformin hydrochloride (MH) is a biguanide oral anti- diabetic drug which is widely used to treat non-insulin dependent diabetes mellitus (type 2 ...mediate release dosage forms of MH such as ...
6
FORMULATION AND EVALUATION OF METFORMIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS USING POLYELECTROLYTE COMPLEXES
... Sustained release tablets and capsules are commonly taken once or twice in a day, compared with conventional tablets which are taken three or four times daily to achieve the same therapeutic ...
11
Formulation Development of Metformin Hydrochloride Sustained Release Tablets
... The release was then completed within the successive 2 h of elution with simulated jejunal fluid (SJF, pH ...dissolved. Release in SGF was controlled by matrix swelling and/or drug diffusion in matrix, ...
137
Development and Charecterisation of Ramipril as Immediate Release and Metformin Hydrochloride as Sustained Release Bilayered Tablets
... as Metformin hydrochloride (Metformin HCl) is not plasma protein bound and does not get metabolized in the liver, so interaction with Ramipril (having 73%plasma protein binding metabolized via liver) ...
8
Formulation and Evaluation of Bilayer Tablets of Losartan Potassium for Immediate Release and Metformin Hydrochloride for Sustained Release
... and release characteristic of a bilayer matrix tablet containing Glimepride immediate release component and Metformin hydrochloride as sustained release ...Immediate ...
141
To study the comparative dissolution profiles of sustained release tablets of metformin hydrochloride by using various hydrophilic polymers
... formulate sustained release matrix tablets of Metformin Hydrochloride as it possesses relatively shorter plasma half-life, low ...The sustained release formulations of the ...
12
Formulation and evaluation of metformin hydrochloride extended release tablets
... Metformin hydrochloride is an orally administered biguanide, which is widely used in the management of type-II diabetes, a common disease that combines defects of both insulin secretion and insulin action ...
7
FORMULATION AND EVALUATION OF EXTENDED RELEASE TABLETS OF METFORMIN HYDROCHLORIDE
... extended release has given a new breakthrough for novel drug delivery system in the field of pharmaceutical ...drug release rate from the dosage form is controlled mainly by the type and proportion of ...
6
DEVELOPMENT AND IN VITRO EVALUATION OF SUSTAINED RELEASE FLOATING MATRIX TABLETS OF METFORMIN HYDROCHLORIDE
... matrix tablets of metformin hydrochloride were developed and evaluated for increase bioavailability by increasing gastric residence time and sustained release of drug on the upper part ...
6
Design and Develop Bilayered Oral Sustained Matrix Tablets of Pioglitazone Hydrochloride and Metformin Hydrochloride
... immediate release into the dissolution ...drug release due to in sufficient polymer concentration in the matrix ...extended release of metformin ...drug release rate ...
111
Formulation and Evaluation of Bilayer Tablets of Metformin Hydrochloride SR and Vildagliptin IR
... for sustained drug delivery from matrices and were ...the sustained release profile over a period of 24 h. Tablets were evaluated for physical properties; drug content and in vitro drug ...
83
FORMULATION AND EVALUATION OF METFORMIN AND GLIMEPIRIDE BILAYERED TABLET
... containing Metformin hydrochloride as sustained release layer and Glimepiride as conventional immediate release ...containing Metformin hydrochloride 1 g exhibits ...
12
“Evaluation of Sustained Release Tablet of Metformin in Alloxan Induced Diabetic Rat” by Sangeeta Mohanty, Abhisek Pal, Sudam Chandra Si, India.
... of Metformin Hydrochloride for sustained release using Hydrophilic synthetic polymer (HPMC K100M) and Natural polymer (Guar gum) as the retardant ...Matrix tablets were prepared by ...
8
DESIGN, FABRICATION AND EVALUATION OF DRUG RELEASE KINETICS FROM METFORMIN HYDROCHLORIDE SUSTAINED RELEASE MATRIX TABLETS BY USING NATURAL GUMS
... in-vitro release of Metformin hydrochloride sustained release ...the release studies were conducted in triplicate and the mean values were plotted versus time with standard ...
8
FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLETS OF MEFORMIN HYDROCHLORIDE
... uptake. Metformin is the only oral antihyperglycemic agent that is not associated with weight ...controlled release dosage forms for water soluble ...
17
Formulation and Evaluation of a Sustained-Release Tablets of Metformin Hydrochloride Using Hydrophilic Synthetic and Hydrophobic Natural Polymers
... compliance. Sustained release products are needed for metformin to prolong its duration of action and to improve patient ...its release behavior and broad regulatory acceptance [6,7] ...
8
Formulation and Development of Sustained Release Matrix Tablets Containing Metformin Hydrochloride
... agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and ...sulfonylureas, metformin ...
7
A Mucoadhesive Bilayer Tablets for the Management of Type-II Diabetes Mellitus
... . Metformin Hydrochloride has limited window of absorption and absorbed from upper part of ...Hence Metformin Hydrochloride formulated as mucoadhesive sustained release ...
8
Formulation of Sustained Release Matrix Tablets of Metformin hydrochloride by Polyacrylate Polymer
... the release rates in hydrophilic matrix tablets prepared by wet granulation ...better sustained release pattern compared to Eudragit RL100 based ...
7